Kaken Pharmaceutical <4521.T>-2007/08 group

May 12 (Reuters) -

KAKEN PHARMACEUTICAL CO LTD

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to Six months to

Mar 31, 2008 Mar 31, 2007 Mar 31, 2009 Sep 30, 2008

LATEST YEAR-AGO COMPANY COMPANY

RESULTS RESULTS FORECASTS H1 FORECASTS
Sales 79.93 76.42 82.80 40.40

(+4.6 pct) (+1.2 pct) (+3.6%) (+2.2%)
Operating 9.84 8.11 10.20 5.30

(+21.3 pct) (-2.9 pct) (+3.6%) (-0.7%)
Recurring 9.35 7.67 9.70 5.00

(+22.0 pct) (+7.4 pct) (+3.7%) (-1.8%)
Net 5.11 4.60 5.60 2.90

(+10.9 pct) (+18.4 pct) (+9.7%) (+2.7%)
EPS Y48.35 Y42.42 Y55.27 Y28.62
Diluted
EPS Y48.11 Y40.83

NOTE - Kaken Pharmaceutical Co Ltd specialises in drugs for practitioners.

For latest earnings estimates made by Toyo Keizai, please
double click on 4521.TK1.